Treatment of hypertension and microalbuminuria in children and adolescents with type 1 diabetes mellitus

Pediatric Diabetes

Volumn 3, Issue 2, 2002, Pages 113-124

  Chiarelli, Francesco ^a,b   Trotta, Daniela ^a   Verrotti, Alberto ^a   Mohn, Angelika ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b Policlinico   (Italy)

Author keywords

Childhood; Diabetes; Hypertension; Microalbuminuria; Treatment

Indexed keywords

AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IRBESARTAN; LISINOPRIL; LOSARTAN; PLACEBO; RAMIPRIL;

ADOLESCENT; ANGIONEUROTIC EDEMA; CHILD; CONTROLLED STUDY; COUGHING; DIABETIC NEPHROPATHY; DRUG CHOICE; FATIGUE; FETOTOXICITY; HUMAN; HYPERKALEMIA; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DIABETES MELLITUS; KIDNEY INJURY; MICROALBUMINURIA; MICROANGIOPATHY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROTEINURIA; PUBERTY; REVIEW; RISK FACTOR; VERTIGO;

EID: 0036053496     PISSN: 1399543X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5448.2002.30209.x     Document Type: Review

References (90)

1. Microalbuminuria, blood pressure and diabetic renal disease. origin and development of ideas
2. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type I (insulin-dependent) diabetes mellitus
3. Preserving renal function in adults with hypertension and diabetes: A consensus approach
4. Is microalbuminuria progressive?
5. Consensus Guidelines
6. Prevention of diabetic renal disease with special reference to microalbuminuria
7. Diabetic nephropathy in childhood and adolescents
8. Diabetic nephropathy in children and adolescents: A critical review with particular reference to angiotensin-converting enzyme inhibitors
9. The importance of microalbuminuria as an indicator of incipient diabetic nephropathy: Therapeutic implications
10. Detection and management of diabetic glomerulopathy in children and adolescents with insulin-dependent diabetes mellitus: Need for improved knowledge and better care
11. Microalbuminuria as prediction of nephropathy in diabetes
12. Predicting diabetic nephropathy in insulin-dependent patients
13. The natural course of microalbuminuria in insulin-dependent diabetes: A 10-year prospective study
14. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion
15. Incipient nephropathy in type 1 (insulin-dependent) diabetes
16. The predictive value of microalbuminuria in IDDM. A five-year follow-up study
17. Proteinuria: Value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus
18. How heterogeneous is microalbuminuria in diabetes mellitus? The case for 'benign' and 'malignant' microalbuminuria
19. Prevalence of microalbuminuria in children with type 1 (insulin-dependent) diabetes mellitus
20. The prevalence of microalbuminuria in diabetic children and adolescents and its relation to puberty
21. A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent) diabetic patients
22. Prevalence of abnormal urinary albumin excretion in adolescents and children with insulin dependent diabetes: The MIDAC study
23. A nation-wide cross-sectional study of urinary albumin excretion rate, arterial blood pressure and blood glucose control in Danish children with type 1 diabetes mellitus
24. Prevalenza di ipertensione in bambini ed adolescenti con T1DM normo e microalbuminurici
25. Elevated albumin excretion and retinal changes in children with type 1 diabetes are related to long-term poor blood glucose control
26. Enhanced progression of urinary albumin excretion in IDDM during puberty
27. Relationship between early metabolic control and the development of microalbuminuria - A longitudinal study in children with type 1 (insulin-dependent) diabetes mellitus
28. Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study
29. Diabetic angiopathy in children
30. Puberty as a risk factor for diabetic neuropathy
31. Persistent microalbuminuria in adolescents with type I (insulin-dependent) diabetes mellitus is associated to early rather than late puberty. Results of a prospective longitudinal study
32. Risk of nephropathy can be detected before the onset of micro-albuminuria during the early years after diagnosis of type 1 diabetes
33. The natural history of microalbuminuria in adolescents with type 1 diabetes
34. Diabetic glomerulopathy in young IDDM patients. Preventive and diagnostic aspects
35. Determinants of progression of microalbuminuria in adolescents with IDDM
36. Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial
37. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus
38. The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial
39. Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy
40. Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries
41. Microalbuminuria is not rare before 5 years of IDDM
42. Recent advances on the pathogenesis and management of both diabetic retinopathy and nephropathy with particular reference to children and adolescents with type 1 diabetes
43. Prevalence of complications in IDDM by sex and duration
44. Diabetes in puberty
45. Growth hormone and IGF-I in diabetic children with and without microalbuminuria
46. Contribution of growth hormone and IGF-I to early diabetic nephropathy in type 1 diabetes
47. Experimental diabetes increases insulinlike growth factor I and II receptor concentration and gene expression in kidney
48. Somatostatin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats
49. Microalbuminuria in diabetic children and adolescents. Relationship with puberty and growth hormone
50. Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes
51. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta-analysis
52. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy
53. Genetics of diabetic nephropathy
54. Influence of insertion/deletion polymorphism in the ACE-I gene on the progression of diabetic glomerulopathy in type 1 diabetic patients with microalbuminuria
55. Prognostic value of angiotensin-I converting enzyme I/D polymorphism for nephropathy in type 1 diabetes mellitus: A prospective study
56. Angiotensin II type 1 receptor gene polymorphisms in humans: Physiology and pathophysiology of the genotypes
57. The need for early predictors of diabetic nephropathy risk: Is albumin excretion rate sufficient?
58. Update on the task force report on high blood pressure in children and adolescents: A working group report from the National High Blood Pressure Education Program
59. What is hypertension in diabetes? Ambulatory blood pressure in 137 normotensive and normoalbuminuric type 1 diabetic patients
60. Relative nocturnal hypertension in children with insulin-dependent diabetes mellitus
61. Hypertension in patients with diabetes. Overcoming barriers to effective control
62. Prevalence and management of hypertension in type 1 diabetes mellitus in Europe: The EURODIAB IDDM Complications Study
63. Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes
64. Diabetes and hypertension how low should you go and with which drugs?
65. Does microalbuminuria predict diabetic nephropathy?
66. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study
67. Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: Relation to glomerular hyperfiltration
68. Low-dose ramipril reduces microalbuminuria in type 1 diabetic patients without hypertension: Results of a randomized controlled trial
69. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data
70. The juxtaglomerular apparatus in young type-1 diabetic patients with microalbuminuria. Effect of antihypertensive treatment
71. Follow-up study of glomerular dimensions and cortical interstitium in microalbuminuric type 1 diabetic patients with or without antihypertensive treatment
72. Renal arterioles in patients with type I diabetes and microalbuminuria before and after treatment with antihypertensive drugs
73. Enlargement of the juxtaglomerular apparatus in insulin-dependent diabetes mellitus patients with microalbuminuria
74. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively
75. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
76. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria
77. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
78. Angiotensin II generation at the cell surface of activated neutrophils: Novel cathepsin G-mediated catalytic activity that is resistant to inhibition
79. Angiotensin II subtype 1 receptor blockers and renal function
80. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
81. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
82. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
83. Renoprotection by angiotensin-receptor blockers and ACE inhibitors in hypertension
84. Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect
85. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with type 1 (insulin-dependent) diabetes mellitus
86. Review of the overall experience of captopril in hypertension
87. Efficacy and safety of captopril in the treatment of severe childhood hypertension: Report of the International Collaborative Study Group
88. Incipient nephropathy in type 1 (insulin dependent) diabetes
89. Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus